BioSure launched the world’s first ever CE marked HIV self test, which enables an end user to find out their own HIV status in private, at a time and place that is convenient to them. The test requires only a tiny drop of blood and gives an easy-to-read, highly accurate result in minutes. In light of the pandemic, the company extended their portfolio to start offering professional COVID 19 testing. 

BioSure has undergone extensive scrutiny and has proactively generated unique, robust evidence and data to prove the acceptability and usability of its HIV self-test, one of only a couple of products certified globally.

In February 2017 BioSure HIV Self Test gained WHO approval as an interim measure before Pre Qualification becomes possible, meaning UNITAID are able to procure the product.